Shares of Beam Therapeutics Inc. (BEAM) have lost nearly 31 percent of their value over the past one month and trade around $19. The stock made its debut on the NASDAQ on February 6, 2020, and the IPO lock-up period is set to expire tomorrow (Aug. 4).
from RTT - Biotech https://ift.tt/2EHNrY9
via IFTTT
No comments:
Post a Comment